Polymorphisms in IL-4/IL-13 Pathway Genes and Glioma Risk: an Updated Meta-analysis

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2014 Dec 5

PMID 25472582

Citations 4

Authors

Peiqin Chen

Chao Chen

Kun Chen

Tao Xu

Chun Luo

Affiliations

Soon will be listed here.

Abstract

Polymorphisms in interleukin (IL)-4/IL-13 pathway genes have previously been reported to be associated with glioma susceptibility, although results are inconsistent. We therefore performed an updated meta-analysis to determine a more precise estimation of this relationship. Twelve eligible studies were identified by searching PubMed, EMBASE, Web of Science, and the Cochrane Library electronic databases. Nine polymorphisms in genes within the IL-4/IL-13 pathway (IL-4 rs2243250, rs2070874, rs2243248, IL-4R rs1805011, rs1805012, rs1805015, rs1801275, and IL-13 rs20541 and rs1800925) were assessed for their relationship with glioma risk by computing odds ratios (ORs) and corresponding 95 % confidence intervals (CIs). Akaike's information criterion (AIC) was used to identify the best genetic model for each polymorphism. No association between IL-4/IL-13 pathway genetic polymorphisms and glioma risk was observed in the overall population, although a significant association was found between rs2234248 and glioblastoma when stratified by histological subtype (log-additive model, OR 1.57, 95 % CI 1.11-2.24). This meta-analysis therefore suggested that IL-4/IL-13 pathway genetic polymorphisms are not associated with glioma risk.

Citing Articles

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma.

Qi Y, Yang X, Ji C, Tang C, Xie L Brain Sci. 2022; 12(2).

PMID: 35203944 PMC: 8870251. DOI: 10.3390/brainsci12020181.

The Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population.

Yang Y, Cheng Y, Yang L, Shi G, Chen P, Li L Cell Mol Neurobiol. 2021; 42(6):1949-1964.

PMID: 33709284 PMC: 11421688. DOI: 10.1007/s10571-021-01075-6.

Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin.

Sun Z, Yan X, Liu Y, Huang L, Kong C, Qu X Oncotarget. 2017; 8(35):58823-58834.

PMID: 28938600 PMC: 5601696. DOI: 10.18632/oncotarget.19221.

Note of the methodological flaws in the paper entitled "Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis".

Wang T, Li J, Zhou D Tumour Biol. 2015; 37(1):199-200.

PMID: 26700665 DOI: 10.1007/s13277-015-4570-0.

References

Sanson M, Hosking F, Shete S, Zelenika D, Dobbins S, Ma Y . Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet. 2011; 20(14):2897-904. PMC: 3118762. DOI: 10.1093/hmg/ddr192. View

Liu H, Jacobs B, Liu J, Prayson R, Estes M, Barnett G . Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother. 2000; 49(6):319-24. PMC: 11036967. DOI: 10.1007/s002620000110. View

Gao L, Pan X, Li L, Liang W, Zhu Y, Zhang L . RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat. 2010; 125(3):827-35. DOI: 10.1007/s10549-010-0995-8. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Sun G, Wang X, Shi L, Yue X, Fu L, Chen C . Association between polymorphisms in interleukin-4Rα and interleukin-13 and glioma risk: a meta-analysis. Cancer Epidemiol. 2013; 37(3):306-10. DOI: 10.1016/j.canep.2013.01.003. View

Brenner A, Butler M, Wang S, Ruder A, Rothman N, Schulte P . Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis. 2007; 28(12):2543-7. DOI: 10.1093/carcin/bgm210. View

Schlehofer B, Siegmund B, Linseisen J, Schuz J, Rohrmann S, Becker S . Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy. 2011; 66(11):1434-41. DOI: 10.1111/j.1398-9995.2011.02670.x. View

Schoemaker M, Swerdlow A, Hepworth S, McKinney P, Van Tongeren M, Muir K . History of allergies and risk of glioma in adults. Int J Cancer. 2006; 119(9):2165-72. DOI: 10.1002/ijc.22091. View

Shete S, Hosking F, Robertson L, Dobbins S, Sanson M, Malmer B . Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009; 41(8):899-904. PMC: 4501476. DOI: 10.1038/ng.407. View

10.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

11.

Backes D, Siddiq A, Cox D, Calboli F, Gaziano J, Ma J . Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol. 2013; 113(2):229-38. PMC: 3679351. DOI: 10.1007/s11060-013-1122-6. View

12.

Wrensch M, Jenkins R, Chang J, Yeh R, Xiao Y, Decker P . Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009; 41(8):905-8. PMC: 2923561. DOI: 10.1038/ng.408. View

13.

Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J . Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol. 2004; 31(6):1206-10. View

14.

Cui L, Jia J, Ma C, Li S, Wang Y, Guo X . IL-13 polymorphisms contribute to the risk of asthma: a meta-analysis. Clin Biochem. 2012; 45(4-5):285-8. DOI: 10.1016/j.clinbiochem.2011.12.012. View

15.

Akdis M . Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol. 2006; 18(6):738-44. DOI: 10.1016/j.coi.2006.06.003. View

16.

Calboli F, Cox D, Buring J, Gaziano J, Ma J, Stampfer M . Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011; 103(21):1588-95. PMC: 3206038. DOI: 10.1093/jnci/djr361. View

17.

Wiemels J, Wiencke J, Kelsey K, Moghadassi M, Rice T, Urayama K . Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev. 2007; 16(6):1229-35. DOI: 10.1158/1055-9965.EPI-07-0041. View

18.

Amirian E, Liu Y, Scheurer M, El-Zein R, Gilbert M, Bondy M . Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol. 2010; 12(5):444-52. PMC: 2940617. DOI: 10.1093/neuonc/nop057. View

19.

Walsh K, Codd V, Smirnov I, Rice T, Decker P, Hansen H . Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014; 46(7):731-5. PMC: 4074274. DOI: 10.1038/ng.3004. View

20.

Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen H . Allergic conditions and brain tumor risk. Am J Epidemiol. 2007; 166(8):941-50. DOI: 10.1093/aje/kwm203. View